COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2780: Articles 27791-27800  | Next

Excess Out-Of-Hospital Mortality and Declining Oxygen Saturation Documented by EMS During the COVID-19 Crisis in Tijuana, Mexico
Friedman, J., Calderon-Villarreal, A., Bojorquez, I., Vera Hernandez, C., Schriger, D., Tovar Hirashima, E.
10.1101/2020.05.13.20098186 — Posted: 2020-05-18
Fusing a Bayesian case velocity model with random forest for predicting COVID-19 in the U.S.
Watson, G. L., Xiong, D., Zhang, L., Zoller, J. A., Shamshoian, J., Sundin, P., Bufford, T., Rimoin, A. W., Suchard, M. A., Ramirez, C. M.
10.1101/2020.05.15.20102608 — Posted: 2020-05-18
When Second Best Might be the Best: Using Hospitalization Data to Monitor the Novel Coronavirus Pandemic
Mallow, P. J., Jones, M.
10.1101/2020.05.11.20098475 — Posted: 2020-05-18
High sensitivity CDC EUA SARS-CoV-2 kit-based End Point-PCR assay.
Freire-Paspuel, B., Vega-Marino, P., Velez, A., Cruz, M., Garcia Bereguiain, M. A.
10.1101/2020.05.11.20098590 — Posted: 2020-05-18
A Proposed Randomized, Double Blind, Placebo Controlled Study Evaluating Doxycycline for the Prevention of COVID-19 Infection and Disease In Healthcare Workers with Ongoing High Risk Exposure to COVID-19
Yates, P. A., Leone, A. M., Reichel, E.
10.1101/2020.05.11.20098525 — Posted: 2020-05-18
Adjusting Coronavirus prevalence estimates for laboratory test kit error
Sempos, C., Tian, L.
10.1101/2020.05.11.20098202 — Posted: 2020-05-18 Discussion: Onsite
Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers
Brochot, E., Demey, B., Touze, A., Belouzard, S., Dubuisson, J., Schmit, J.-L., Duverlie, G., Francois, C., Castelain, S., Helle, F.
10.1101/2020.05.12.20098236 — Posted: 2020-05-18
Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes
Galbadage, T., Peterson, B. M., Awada, J., Buck, A. S., Ramirez, D. A., Wilson, J., Gunasekera, R. S.
10.1101/2020.05.11.20098673 — Posted: 2020-05-18
Bounding the Predictive Values of COVID-19 Antibody Tests
Manski, C. F.
10.1101/2020.05.14.20102061 — Posted: 2020-05-18
Distinct systems serology features in children, elderly and COVID patients
Selva, K. J., van de Sandt, C. E., Lemke, M. M., Lee, C. Y., Shoffner, S. K., Chua, B. Y., Nguyen, T. H. O., Rowntree, L. C., Hensen, L., Koutsakos, M., Wong, C. Y., Jackson, D. C., Flanagan, K. L., Crowe, J., Cheng, A. C., Doolan, D. L., Amanat, F., Krammer, F., Chappell, K., Modhiran, N., Watterson, D., Young, P., Wines, B., Hogarth, P. M., Esterbauer, R., Kelly, H. G., Tan, H.-X., Juno, J. A., Wheatley, A. K., Kent, S. J., Arnold, K. B., Kedzierska, K., Chung, A. W.
10.1101/2020.05.11.20098459 — Posted: 2020-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).